- Home
- Companies
- canada nova scotia
- gene expression
Refine by
Gene Expression Suppliers Serving Nova Scotia
149 companies found
Premium
based inFramingham, MASSACHUSETTS (USA)
SCIEX empowers you to solve the most impactful analytical challenges in quantitation and characterization in environmental testing. With groundbreaking innovation and outstanding reliability and support, SCIEX has been at the forefront of the field ...
All your genetic analyses needs on a single instrument. The GenomeLab GeXP supports a variety of applications, including DNA sequencing, fragment analysis and multiplex gene expression. Are you seeking an ideal ...
Premium
based inDueren, GERMANY
Since 2005, NIPPON Genetics EUROPE has stood for innovation and quality in biotechnology. In these two decades, we have evolved from a supplier of high quality Japanese technologies to a developer of our own groundbreaking solutions. Our products ...
Real-time fluorescent quantitative PCR system 6 channels for probe & dye-based assays. The FastGene® qFYR is a highest precision instrument for performing quantitative polymerase chain reaction (qPCR) experiments. qPCR is a well-established ...
based inEtoy, SWITZERLAND
Nuproxa Switzerland Ltd is dedicated to the development of innovative natural solutions to meet the challenges in animal production. Specializing in products that enhance animal nutrition and health, Nuproxa offers a range of solutions targeting ...
based inDavis, CALIFORNIA (USA)
Located in Davis, CA, Aves Labs develops novel antibody reagents against neural-specific antigens and epitope tags to foster scientific progress in neuroscience and the molecular biology communities. Aves Labs was co-founded in 1995 by Gary Ciment ...
Staining of a tissue section through the midbrain region of an adult mouse for GFP (green) and Tryptophan Hydroxylase-positive neurons (RED). ...
based inBrighton, UNITED KINGDOM
Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. We have two exciting late-stage clinical assets and a range of earlier research programmes. Our ...
Background to the NTCD-M3 Clostridioides difficile Programme. NTCD-M3 was developed by GI infection physician, Professor Dale Gerding, who is a world-leading specialist in C. difficile, with more than 400 peer-reviewed journal publications, book ...
based inShirley, NEW YORK (USA)
CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems. We specialize in a range of formulation and drug delivery technologies, from ...
based inSan Diego, CALIFORNIA (USA)
Everyone at AnaBios shares a passion and commitment to make a difference in the development of promising new therapies and cures for patients by reducing the time and expense needed to bring these medicines to patients. We do this by generating ...
AnaBios offers high quality human brain and other neurological tissue samples recovered via our propriety methods. Tissue recovery may be customized to meet your specific experimental needs. AnaBios offers normal and diseased human tissue samples. ...
based inThorold, ONTARIO (CANADA)
Norgen Biotek Corp. is dedicated to providing our customers with first class sample preparation kits for RNA, microRNA, DNA and protein purification, clean-up and concentration and to provide dedicated and expert support services to our customers ...
This kit provides a convenient and rapid method to purify total RNA from small amounts of stool samples. All types of stool samples can be processed with this kit, including animal fecal samples, manure and samples collected using Norgen's Stool ...
based inShirley, NEW YORK (USA)
CD BioSciences is a leading customer-focused biotechnology company founded in New York. Virus-like particles (VLPs) constructed on plant-based platforms can be produced on a large scale as plants can be grown cheaply and efficiently without the need ...
Virus-like particles (VLPs) are nanoscale structures composed of assembled viral proteins that lack viral genetic material and are therefore not infectious. CD BioSciencesoffers VLPlantTM, a plant-based recombinant expression system for constructing ...
based inDavis, CALIFORNIA (USA)
Headquartered in Davis, California, Expression Systems is dedicated to supplying and servicing the baculovirus, cell culture and bio-industrial markets with innovative media formulations, complementary products and contract services. We specialize ...
Expression Systems’ contract production services can assist you at any step of the process, solving technical problems in molecular biology, purification or other issues relating to BEVS. ...
based inMadison, WISCONSIN (USA)
Mirus continued the development of a wide range of non-viral delivery technologies using proteins, polymers, and lipids in conjunction with novel chemistries that provided unique nucleic acid delivery capabilities. Our work at Mirus Bio began with a ...
Insect cell expression is a platform used to produce proteins with simple post-translational modifications. Transient transfection and recombinant baculovirus production are commonly used methods for insect cell ...
based inJupiter, FLORIDA (USA)
Dyadic International, Inc. (NASDAQ: DYAI) is a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable, and ...
based inFrankfurt, GERMANY
NeraCare develops and commercializes molecular diagnostic tests for patients with skin cancer. The tests provide actionable, tumor-specific information for each individual patient. The information is used to make improved treatment decisions, i.e. ...
Melanoma is a serious form of skin cancer that begins in cells known as melanocytes. While it is less common than basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), melanoma is far more dangerous because of its ability to spread to other ...
based inHradec Králové, CZECH REPUBLIC
GENERI BIOTECH was established in 1995, originally as a facility for production of oligonucleotides. We are focusing on R&D, manufacturing and selling of own proprietary products such as real-time PCR CE IVD kits, Life Sciences products and ...
Detection method: allelic discrimination, real-time PCR; This in vitro diagnostic kit is intended for detection of mutation 4G/5G in PAI1 gene promotor in human genomic DNA. Detection is based on real-time polymerase chain reaction (qPCR) using ...
based inWaltham, MASSACHUSETTS (USA)
Evident, we’re building on this legacy with a continued commitment to pushing the limits of discovery. Today, as Evident, we’re building on a century of optical superiority to create next-generation micro-imaging solutions—combining renowned optics ...
based inTralee, IRELAND
BioAtlantis was established in 2004 and entered the crop biostimulant market in 2007 with stress mitigation as a central strategy. Stress is now recognised worldwide as affecting most life forms. It can be split into two main categories, abiotic and ...
based inAbingdon, UNITED KINGDOM
PsiOxus is a clinical-stage company redefining therapies for solid tumors with the goal of curing patients with cancer. Our clinically validated, systemically dosed T-SIGn® viral vector platform delivers tumor-localized production of combinations of ...
Our clinically validated T-SIGn® viral vector platform delivers multiple transgene payloads that re-program the tumor microenvironment of both primary and metastatic tumors. Our platform can integrate rationally designed synthetic agents to ...
based inNewcastle Upon Tyne, UNITED KINGDOM
Newcells offers expert disease modelling services using best in class in vitro platforms and supports drug development by providing robust data for regulatory submissions and the critical decision-making process. Newcells mission is to de-risk the ...
In vitro retinal disease modelling for retinal therapy. Newcells offers a fast and reliable in vitro safety and efficacy service for the evaluation of novel compounds for retinal therapy using complex human retinal organoid or RPE models developed ...
based inParis, FRANCE
Biogemma is a European plant biotechnology company founded in 1997 by seed companies and French field crop producers. Its original mission was to create new genetic variability via GM traits to be exploited by its shareholding companies. With the ...
Biogemma is built around 4 core platforms in 4 species, and an upstream technology ...
based inMalvern, PENNSYLVANIA (USA)
Since our founding in 2001, we have had one singular obsession: We strive to give our clients a personalized and collaborative research experience. We are here to help you find the answers you need to develop the best possible drug candidate for ...
In collaboration with the bioinformatics firm 4HF Biotech GmbH which is a bioinformatics firm specializing in cancer data mining to discover new anti-cancer drugs, we offer data mining for analysis of the genetic signature of tumor cell lines that ...
